AAPS Announces 2018 Slate of Candidates
The American Association of Pharmaceutical Scientists (AAPS) board of directors announced the candidates for the 2018 AAPS board.
On June 1, 2018, the American Association of Pharmaceutical Scientists (AAPS) board of directors announced the candidates for the 2018 AAPS board.
Open nominations were accepted through the AAPS website, emails to membership, and the AAPS Newsmagazine in early 2018. Elections will be held in June/July 2018, with the new slate of board members beginning their term in November 2018 at the AAPS PharmSci 360 meeting in Washington, DC. The AAPS Nominations Committee considered the knowledge, skill sets, and attitudes necessary to lead AAPS in advancing the organization’s mission. The organization aims to advance the capacity of pharmaceutical scientists to develop products and therapies that improve global health.
The candidates for president-elect are Joseph W. Polli, PhD, FAAPS, GlaxoSmithKline and Gopi Shankar, PhD, MBA, FAAPS, Janssen R&D (Johnson & Johnson).
Candidates for treasurer are Mark J. Rose, PhD, CHDI Management and William E. Weiser, PhD,
Patheon, part of Thermo Fisher Scientific.
Member-at-large candidates are Meena Subramanyam, PhD, Takeda Pharmaceutical Company and Douglas H. Sweet, PhD, Virginia Commonwealth University.
The voting deadline is July 31, 2018 and results will be announced in August, according to the association in a press release.
Source: AAPS
Drug Solutions Podcast: A Closer Look at mRNA in Oncology and Vaccines
April 30th 2024In this episode fo the Drug Solutions Podcast, etherna’s vice-president of Technology and Innovation, Stefaan De Koker, discusses the merits and challenges of using mRNA as the foundation for therapeutics in oncology as well as for vaccines.
A Novel, Enhanced, and Sustainable Approach to Audit Trail Review
July 4th 2025Eli Lilly and Company developed an innovative and sustainable approach to audit trail review (ATR) aimed at reducing the ATR burden while adhering to regulatory expectations and data integrity (DI) principles. The process has transformed employees' understanding of ATR and complemented the DI by design approach, leading to better system designs that meet expected controls and reduce non-value-added data reviews.
Drug Solutions Podcast: Gliding Through the Ins and Outs of the Pharma Supply Chain
November 14th 2023In this episode of the Drug Solutions podcast, Jill Murphy, former editor, speaks with Bourji Mourad, partnership director at ThermoSafe, about the supply chain in the pharmaceutical industry, specifically related to packaging, pharma air freight, and the pressure on suppliers with post-COVID-19 changes on delivery.
